BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 29603279)

  • 1. Long-Term Therapy With Teduglutide in Parenteral Support-Dependent Patients With Short Bowel Syndrome: A Case Series.
    Ukleja A; To C; Alvarez A; Lara LF
    JPEN J Parenter Enteral Nutr; 2018 May; 42(4):821-825. PubMed ID: 29603279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Response to Teduglutide in Patients With Short-Bowel Syndrome and Intestinal Failure.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Gastroenterology; 2018 Mar; 154(4):874-885. PubMed ID: 29174926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: A real-world French observational cohort study.
    Joly F; Seguy D; Nuzzo A; Chambrier C; Beau P; Poullenot F; Thibault R; Armengol Debeir L; Layec S; Boehm V; Lallemand J; Quilliot D; Schneider SM
    Clin Nutr; 2020 Sep; 39(9):2856-2862. PubMed ID: 31932048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study.
    Jeppesen PB; Pertkiewicz M; Forbes A; Pironi L; Gabe SM; Joly F; Messing B; Loth S; Youssef NN; Heinze H; Berghöfer P
    Clin Nutr; 2013 Oct; 32(5):713-21. PubMed ID: 23587733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independence From Parenteral Nutrition and Intravenous Fluid Support During Treatment With Teduglutide Among Patients With Intestinal Failure Associated With Short Bowel Syndrome.
    Iyer KR; Kunecki M; Boullata JI; Fujioka K; Joly F; Gabe S; Pape UF; Schneider SM; Virgili Casas MN; Ziegler TR; Li B; Youssef NN; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):946-951. PubMed ID: 27875291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral Autonomy and Days Off Parenteral Support With Teduglutide Treatment for Short Bowel Syndrome in the STEPS Trials.
    Seidner DL; Gabe SM; Lee HM; Olivier C; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):697-702. PubMed ID: 31423614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Teduglutide: a guide to its use in short bowel syndrome.
    McKeage K
    Clin Drug Investig; 2015 May; 35(5):335-40. PubMed ID: 25859983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure.
    Chen K; Mu F; Xie J; Kelkar SS; Olivier C; Signorovitch J; Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2020 Jan; 44(1):119-128. PubMed ID: 31006876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
    Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
    Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
    Kocoshis SA; Merritt RJ; Hill S; Protheroe S; Carter BA; Horslen S; Hu S; Kaufman SS; Mercer DF; Pakarinen MP; Venick RS; Wales PW; Grimm AA
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with teduglutide treatment for short bowel syndrome in clinical practice.
    Pevny S; Maasberg S; Rieger A; Karber M; Blüthner E; Knappe-Drzikova B; Thurmann D; Büttner J; Weylandt KH; Wiedenmann B; Müller VA; Bläker H; Pascher A; Pape UF
    Clin Nutr; 2019 Aug; 38(4):1745-1755. PubMed ID: 30145039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K; Schwartz L; Batisti J; Iyer KR
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Teduglutide in Infants and Children With Short Bowel Syndrome Dependent on Parenteral Support.
    Chiba M; Masumoto K; Kaji T; Matsuura T; Morii M; Fagbemi A; Hill S; Pakarinen MP; Protheroe S; Urs A; Chen ST; Sakui S; Udagawa E; Wada M
    J Pediatr Gastroenterol Nutr; 2023 Sep; 77(3):339-346. PubMed ID: 37364133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult patients with short bowel syndrome treated with teduglutide: A descriptive cohort study.
    Daoud DC; Schwenger KJP; Jung H; Lou W; Armstrong D; Raman M; McHattie JD; Duerksen DR; Whittaker S; Bielawska B; Jurewitsch B; Gramlich L; Allard JP
    JPEN J Parenter Enteral Nutr; 2023 Sep; 47(7):878-887. PubMed ID: 37416984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.